Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103012175A details water-soluble curcumin salts. Enhances stability and bioavailability for pharmaceutical manufacturing.
Discover the full liquid-phase synthesis method for Gonadorelin outlined in patent CN113603752A, offering superior purity over 95% and significant cost reductions for pharmaceutical supply chains.
Patent CN109912474A reveals lactic acid catalyzed route for high-purity pharmaceutical intermediates. Scalable, cost-effective, and environmentally friendly manufacturing process.
Novel bromination method reduces costs and improves safety for sartan drug intermediates with high atom economy and scalable production capabilities.
Patent CN109912474A reveals lactic acid catalyzed route. High purity, scalable, cost-effective intermediate manufacturing.
Patent CN109970516A details high-purity cannabinoid synthesis. Delivers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN101624336A reveals a green copper-catalyzed oxidation route for oxo-ionones, offering high purity and eliminating toxic chromium waste for reliable supply chains.
Patent CN111944855B details a high-yield enzymatic route for (R)-1-(4-(benzyloxy)-3-nitrophenyl)-2-bromoethanol, offering superior stereoselectivity.
Patent CN101899044B reveals a greener route for Gemifloxacin main ring synthesis, eliminating hazardous reagents like NaH and ensuring reliable supply chain continuity.
Patent CN102976924B reveals asymmetric synthesis for high-purity intermediates. Enables cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN111484412A reveals a solid acid catalyzed route for high-purity indane diamines, offering significant cost reduction in polyimide manufacturing and enhanced supply chain reliability.
Patent CN110105368B reveals novel deoxy taxane synthesis improving solubility and anticancer activity, offering cost-effective API intermediate manufacturing strategies.
Novel synthesis route for high-purity antitumor intermediates reducing waste and cost for pharmaceutical manufacturing supply chains globally.
Patent CN101781200B reveals a green amine transesterification method using ionic liquids, offering cost-effective and scalable production for pharmaceutical intermediates.
Patent CN111471003B details a cost-effective Negishi coupling route for sitagliptin intermediates, offering high purity and scalable manufacturing solutions.
Patent CN101157655A details a novel cinchona alkaloid-catalyzed route for (4S,5R)-half esters, offering superior yield and enantioselectivity for scalable biotin production.
Advanced catalytic oxidation route for 5-chloro-2-pentanone production. Delivers high purity and cost reduction in API manufacturing with scalable green chemistry.
Patent CN116348474B discloses efficient oxazoline sugar synthesis enabling specific peptide modification and complex molecule assembly for pharmaceutical research.
Novel oxidative esterification method using metalloporphyrins offers high selectivity and mild conditions for efficient carboxylic acid ester manufacturing.
Patent CN106045891A reveals efficient one-pot synthesis for Vildagliptin intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing.